Endogenous retroviruses and human disease

Expert Review of Clinical Immunology

Volumn 2, Issue 1, 2006, Pages 149-167

  Dolei, Antonina ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GAG PROTEIN; GAMMA INTERFERON; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DQB1 ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 6; POL PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

CYTOKINE PRODUCTION; DISEASE COURSE; DNA METHYLATION; DNA MODIFICATION; ENHANCER REGION; FIRST TRIMESTER PREGNANCY; GENE INSERTION; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; LEUKEMIA; LONG TERMINAL REPEAT; MULTIPLE SCLEROSIS; NIDATION; NONHUMAN; PREECLAMPSIA; PROMOTER REGION; PROTEIN EXPRESSION; PSORIASIS; RETROVIRUS; REVIEW; RHEUMATOID ARTHRITIS; RNA SEQUENCE; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION; TRANSPOSON; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS PATHOGENESIS;

EID: 33748512401     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.2.1.149     Document Type: Review

References (154)

1. Tristem M. Identification and characterisation of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J. Virol. 74, 3715-3730 (2000).
2. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
3. Nelson PN, Hooley P, Roden D et al. Human endogenous retroviruses: transposable elements with potential? Clin. Exp. Immunol. 138, 1-9 (2004).
4. Bosch E, Jobling MA. Duplications of the AZFa region of the human Y chromosome are mediated by homologous recombination between HERVs and are compatible with male fertility. Hum. Mol. Genet. 12, 341-347 (2003).
5. Deininger PL, Batzer MA. Mammalian retroelements. Genome Res. 12, 1455-1465 (2002).
6. Costas J. Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W. Mol. Biol. Evol. 19, 526-533 (2002).
7. Ostertag EM, Kazazian HH. Biology of mammalian L1 retrotransposons. Ann. Rev. Genet. 35, 501-538 (2001).
8. Fukuyama Y, Osawa M, Suzuki H. Congenital muscular dystrophy of the Fukuyama type-clinical, genetic and pathological considerations. Brain Dev. 3, 1-30 (1981).
9. Kobayashi K, Nakahori Y, Miyake M et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388-392 (1998).
10. Kim TH, Jeon YJ, Yi JM et al. The distribution and expression of HERV families in the human genome. Mol. Cells 18, 87-93 (2004).
11. Villesen P, Aagaard L, Wiuf C et al. Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1(1), 32 (2004).
12. Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl Acad Sci. USA 101(Suppl. 2), 14572-14579 (2004).
13. Larsson E, Andersson G. Beneficial role of human endogenous retroviruses: facts and hypotheses. Scand. J. Immunol. 48, 329-338 (1998).
14. Mamedov I, Lebedev Y, Hunsmann H et al. A rare event of insertion polymorphism of a HERV-K LTR in the human genome. Genomics 84, 596-599 (2004).
15. Nelson PN, Carnegie PR, Martin J et al. Demystified. Human endogenous retroviruses. J. Clin. Pathol. Mol. Pathol. 56, 11-18 (2003).
16. Pavlicek A, Paces J, Elleder D et al. Processed pseudogenes of human endogenous retroviruses generated by LINES: their integration, stability, and distribution. Genome Res. 12, 391-399 (2002).
17. Urnovitz HB, Murphy WH. Human endogenous retroviruses: Nature occurrence, and clinical implications in human disease. Clin. Microbiol. Rev. 9, 72-99 (1996).
18. Ryan FP. Human endogenous retroviruses in health and disease: a symbiotic perspective. J R Soc. Med. 97, 560-565 (2004).
19. Kalter SS, Helmke RJ, Heberling RL et al. C-type particles in normal human Placentas. J. Natl Cancer Inst. 50, 1081-1084 (1973).
20. Rote NS, Chakrabarti S, Stetzer BP. The role of human endogenous retroviruses in trophoblast differentiation and Placental development. Placenta 25, 673-683 (2004).
21. de Parseval N, Lazar V, Casella JF et al. Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins. J. Virol. 77, 10414-10422 (2003).
22. Blaise S, de Parseval N, Benit L, Heidmann T. Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc. Natl Acad. Sci. USA 100, 13013-13018 (2003).
23. Blaise S, Ruggieri A, Dewannieux M et al. Identification of an envelope protein from the FRD family of human endogenous retroviruses (HERV-FRD) conferring infectivity and functional conservation among simians. J. Virol. 78, 1050-1054 (2004).
24. Mi S, Lee X, Li X et al. Syncytin is a captive retroviral envelope protein involved in human Placental morphogenesis. Nature 403, 785-789 (2000).
25. Muir A, Lever A, Moffett A. Expression and functions of human endogenous retroviruses in the Placenta: an update. Placenta 26, S16-S25 (2004).
26. Venables PJ, Brookes SM, Griffiths D et al. Abundance of an endogenous retroviral envelope protein in Placental trophoblasts suggests a biological function. Virology 211, 589-592 (1995).
27. Malassiné A, Handschuh K, Tsatsaris V et al. Expression of HERV-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human Placenta. Placenta 26, 556-562 (2004).
28. Blond JL, Beseme F, Duret L et al. Molecular characterisation and Placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol. 73, 1175-1185 (1999).
29. Wei S, Charmley P, Concannon P. DNA sequence and polymorphism analysis of a region of the T-cell receptor beta locus thought to contain a susceptibility gene for multiple sclerosis. Ann. NY Acad. Sci. 756, 307-309 (1995).
30. Frendo J-L, Olivier D, Cheynet V et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol. Cell. Biol. 23, 3566-3574 (2003).
31. Villareal LP. On viruses, sex, and motherhood. J. Virol. 71, 859-865 (1997).
32. Dolei A. MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usablity and the hazard of a human endogenous retrovirus. J. NeuroVirol. 11, 232-235 (2005).
33. Stoye JP, Coffin JM. A provirus put to work. Nature 403, 715-717 (2000).
34. Lee X, Keith JC Jr, Stumm N et al. Downregulation of Placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 22, 808-812 (2001).
35. Knerr I, Beinder E, Rascher W. Syncytin, a novel human endogenous retroviral gene in human Placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am. J. Obstet. Gynecol. 186, 210-213 (2002).
36. Kudo Y, Boyd CAR, Sargent IL et al. Hypoxia alters expression and function of syncytin and its receptor during trophoblast cell fusion of human placental BeWo cells: implications for impaired trophoblast syncytialization in pre-eclampsia. Biochim. Biophys. Acta. 1638, 63-71 (2003).
37. Herbst H, Sauter M, Kuhler-Obbarius C et al. Human endogenous retrovirus (HERV)-K transcripts in germ cell and trophoblastic tumours. APMIS 106, 216-220 (1998).
38. Noseworthy JH, Lucchinetti C, Rodriguez M et al. Multiple sclerosis. N. Engl. J. Med. 343, 938-952 (2000).
39. Perron H, Geny C, Laurent A et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res. Virol. 140, 551-561 (1989).
40. Komurian-Pradel F, Paranhos-Baccala G, Bedin F et al. Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 260, 1-9 (1999).
41. Garson J, Tuke PW, Giraud P et al. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 351, 33 (1998).
42. Clausen J. Endogenous retroviruses and MS: using ERVs as disease markers. Int. MS J. 10, 20-21 (2003).
43. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol. 15, 179-211 (2005).
44. Dolei A, Serra C, Mameli G et al. Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 58, 471-473 (2002).
45. Perron H, Lazarini F, Ruprecht K et al. Human endogenous retrovirus (HERV)-W ENV and GAG-proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J. NeuroVirol. 11, 23-33 (2005).
46. Perron H, Garson JA, Bedin F et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc. Natl Acad. Sci. USA 94, 7583-7588 (1997).
47. Serra C, Sotgiu S, Mameli G et al. Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol. Sci. 22, 171-174 (2001).
48. Nowak J, Januszkiewicz D, Pernak M et al. Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients. J. NeuroVirol. 9, 112-117 (2003).
49. Mirsattari SM, Johnston JB, McKenna R et al. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 56, 317-323 (2001).
50. Zawada M, Liwen I, Pernak M et al. MSRV pol sequence copy number as a potential marker of multiple sclerosis. Pol. J. Pharmacol. 55, 869-875 (2003).
51. Sotgiu S, Serra C, Mameli G et al. Multiple sclerosis (MS)-associated retrovirus and MS prognosis: an observational study. Neurology 59, 1071-1073 (2002).
52. Johnston JB, Silva C, Holden J et al. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann. Neurol. 50, 434-442 (2001).
53. Antony JM, Van Marle G, Opii W et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7, 1088-1095 (2004).
54. Mameli G, Astone V, Arru G et al. Brains from multiple sclerosis patients overexpress human endogenous retrovirus HERV-W/MSRV, but not human herpesvirus-6. (Submitted)
55. Serra C, Mameli G, Arru G et al. In vitro modulation of the multiple sclerosis (MS)-associated retrovirus (MSRV) by cytokines: implications for MS pathogenesis. J. NeuroVirol. 9, 1-7 (2003).
56. Firouzi R, Rolland A, Jouvin-Marche E et al. Multiple sclerosis associated retrovirus particles cause T-lymphocyte dependent death with brain hemorrage in humanized SCID mice model. J. Neurovirol. 9, 79-93 (2003).
57. Rolland A, Jouvin-Marche E, Saresella M et al. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis. J. Neuroimmunol. 160, 195-203 (2005).
58. Perron H, Firouzi R, Tuke P et al. Cell cultures and associated retroviruses in multiple sclerosis. Collaborative Research Group on MS. Acta Neurol. Scand. Suppl. 169, 22-31 (1997).
59. Perron H, Jouvin-Marche E, Ounanian-Paraz A et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vf16 T-lymphocyte activation. Virology 287, 321-332 (2001).
60. Menard A, Amouri R, Michel M et al. Gliotoxicity, reverse transcriptase activity and retroviral RNA in monocyte/macrophage culture supernatants from patients with multiple sclerosis. FEBS Lett. 413, 477-485 (1997).
61. Lafon M, Jouvin-Marche E, Marche PN et al. Human viral superantigens: to be or not to be transactivated? Trends Immunol. 23, 238-239 (2002).
62. Perron H, Suh M, Lalande B et al. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J. Gen. Virol. 74, 65-72 (1993).
63. Brudek T, Christensen T, Hansen HJ et al. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res. Hum. Retroviruses 20, 415-423 (2004).
64. Jolivet-Reynaud C, Perron H, Ferrante P et al. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes. Clin. Immunol. 93, 283-293 (1999).
65. Trabattoni D, Ferrante P, Fusi ML et al. Augmented Type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis. J. NeuroVirol. 6(Suppl. 2), S38-S41 (2000).
66. Clerici M, Fusi ML, Caputo D et al. Immune responses to antigens of human endogenous retroviruses in patients with acute or stable multiple sclerosis. J. Neuroimmunol. 99, 173-182 (1999).
67. Christensen T, Dissing Sorensen P et al. Molecular characterization of HERV-H variants associated with multiple sclerosis. Acta. Neurol. Scand 101, 229-238 (2000).
68. Christensen T, Dissing-Sorensen P, Riemann H et al. Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis. Lancet 352, 1033 (1998).
69. Christensen T, Sorensen PD, Hansen HJ et al. Antibodies against a human endogenous retrovirus and the preponderance of env splice variants in multiple sclerosis patients. Mult. Scler. 9, 6-15 (2003).
70. Perron H, Perin JP, Rieger F et al. Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'hain-reaction' triggered by infectious agents in multiple sclerosis? J. Neurovirol. 6(Suppl. 2), S67-S75 (2000).
71. Karlsson H, Bachmann S, Schroder J et al. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc. Natl Acad. Sci. USA 98, 4634-4649 (2001).
72. Nakamura A, Okazaki Y, Sugimoto J et al. Human endogenous retroviruses with transcriptional potential in the brain. J. Hum. Genet. 48, 575-581 (2003).
73. Karlsson H, Schroder J, Bachmann S et al. HERV-W related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Mol. Psychiatry 9, 12-13 (2004).
74. Deb-Rinker, Klempan TA, O'Reilly R et al. Molecular characterization of a MSRV-like sequence identified by RDA from monozygotic twin pairs discordant for schizophrenia. Genomics 61, 133-144 (1999).
75. Deb-Rinker P, O'Reilly RL, Torrey EF et al. Molecular characterization of a 2.7-kb, 12q13-specific, retroviral-related sequence isolated by RDA from monozygotic twin pairs discordant for schizophrenia. Genome 45, 381-390 (2002).
76. Jaeckel E, Manns M, Von Herrath M. Viruses and diabetes. Ann. NY Acad. Sci. 958, 7-25 (2002).
77. Badenhoop K, Donner H, Neumann J et al. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes 48, 215-218 (1999).
78. Lower R, Tonjes R, Boller K et al. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 95, 11-14 (1998).
79. Todd JA. From genome to aetiology in a multifactorial disease, Type 1 diabetes. Bioessays 21, 164-174 (1999).
80. Thomsen M, Molvig J, Zerbib A et al. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLADR3,4 heterozygotes. Immunogenetics 28, 320-327 (1988).
81. Badenhoop K, Tonjes RR, Rau H et al. Endogenous retroviral long-terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus. Hum. Immunol. 50, 103-110 (1996).
82. Bieda K, Pani MA, van der Auwera B et al. A retroviral long-terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies Type I diabetes susceptibility on high risk DQ haplotypes. Diabetologia 45, 443-447 (2002).
83. Dangel AW, Mendoza AR, Baker BJ et al. The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 40, 425-436 (1994).
84. Pani MA, Wood JP, Bieda K et al. The variable endogenous retroviral insertion in the human complement C4 gene: a transmission study in Type I diabetes mellitus. Hum. Immunol. 63, 481-484 (2002).
85. Marguerat S, Wang WY, Todd JA et al. Association of human endogenous retrovirus K-18 polymorphisms with Type 1 diabetes. Diabetes 53, 852-854 (2004).
86. Somoza N, Vargas F, Roura-Mir C et al. Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J. Immunol. 153, 1360-1377 (1994).
87. Luppi P, Zanone MM, Hyoty H et al. Restricted TCR V beta gene expression and enterovirus infection in Type I diabetes: a pilot study. Diabetologia 43, 1484-1497 (2000).
88. Conrad B, Weissmahr RN, Boni J et al. A human endogenous retroviral superantigen as candidate autoimmune gene in Type I diabetes. Cell 90, 303-313 (1997).
89. Stauffer Y, Marguerat S, Meylan F et al. Interferon-alpha-induced endogenous superantigen: a model linking environment and Autoimmunity Immunity 15, 591-601 (2001).
90. Sutkowski N, Conrad B, Thorley-Lawson DA, Riemann H et al. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15, 579-589 (2001).
91. Kinjo Y, Matsuura N, Yokota Y et al. Identification of nonsynonymous polymorphisms in the superantigen-coding region of IDDMKI,2 22 and a pilot study on the association between IDDMK1,2 22 and Type 1 diabetes. J. Hum. Genet. 46, 712-716 (2001).
92. Gaudin P, Ijaz S, Tuke PW et al. Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritis. Rheumatology 39, 950-954 (2000).
93. Perl A. Role of endogenous retroviruses in autoimmune diseases. Rheum. Dis. Clin. North Am. 29, 123-143 (2003).
94. Perron H, Seigneurin JM. Human retroviral sequences associated with extracellular particles in autoimmune diseases: epiphenomenon or possible role in aetiopathogenesis? Microbes Infect. 1, 309-322 (1999).
95. Pani MA, Seidl C, Bieda K, Seissler J et al. Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clin. Endocrinol. 56, 773-777 (2002).
96. Donner H, Tonjes RR, van der Auwera B et al. The presence or absence of a retroviral long-terminal repeat influences the genetic risk for Type 1 diabetes conferred by human leukocyte antigen DQ haplotypes. Belgian Diabetes Registry. J. Pediatr. Endocrinol. Metab. 84, 1404-1408 (1999).
97. Seidl C, Donner H, Petershofen E et al. An endogenous retroviral long-terminal repeat at the HLA-DQB1 gene locus confers susceptibility to rheumatoid arthritis. Hum. Immunol. 60, 63-68 (1999).
98. Pascual M, Martin J, Nieto A et al. Distribution of HERV-LTR elements in the 5′-flanking region of HLA-DQB1 and association with autoimmunity. Immunogenetics 53, 114-118 (2001).
99. Dawkins R, Leelayuwat C, Gaudieri S et al. Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol. Rev. 167, 275-304 (1999).
100. Nelson PN, Lever AM, Smith S et al. Molecular investigations implicate human endogenous retroviruses as mediators of antiretroviral antibodies in autoimmune rheumatic disease. Immunol. Invest. 28, 277-289 (1999).
101. Gaudin P, Perron H, Favre G et al. Detection of retrovirus MSRV in RA and other diseases. RNA in plasma of rheumatoid arthritis. Arthritis Rheum. 40(Suppl.), 1285 (1997) (Abstract).
102. Nakagawa K, Brusic V, McColl G et al. Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum. 40, 627-638 (1997).
103. Herve CA, Lugli EB, Brand A et al. Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin. Exp. Immunol. 128, 75-82 (2002).
104. Sibata M, Ikeda H, Katumata K et al. Human endogenous retroviruses: expression in various organs in vivo and its regulation in vitro. Leukemia 11(Suppl.), 145-146 (1997).
105. Piotrowski PC, Duriagin S, Jagodzinski PP. Expression of human endogenous retrovirus done 4-1 may correlate with blood plasma concentration of antiU1 RNP and antiSm nuclear antibodies. Clin. Rheumatol. 24(6), 620-624 (2005).
106. Meylan F, De Smedt M, Leclercq G et al. Negative thymocyte selection to HERV-K18 superantigens in humans. Blood 105, 4377-4382 (2005).
107. Ogasawara H, Hishikawa T, Sekigawa I et al. Sequence analysis of human endogenous retrovirus done 4-1 in systemic lupus erythematosus. Autoimmunity 33, 15-21 (2000).
108. Januchowski R, Prokop J, Jagodzinski PP. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J. Appl. Genet. 45, 237-248 (2004).
109. Lu Q, Kaplan M, Ray D et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 46, 1282-1291 (2002).
110. Herrmann M, Voll RE, Zollero OM et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41, 1241-1250 (1998).
111. Bennett RM, Pellet JS, Merritt MM. Defective DNA-receptor function in systemic lupus erythematosus and related diseases: evidence for an autoantibody influencing cell physiology. Lancet 1, 186-188 (1986).
112. Okada M, Ogasawara H, Kaneko H et al. Role of DNA methylation in transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus. J. Rheumatol. 29, 1678-1682 (2002).
113. Krieg AM. CpG DNA: a pathogenic factor in systemic lupus erythematosus? J. Clin. Immunol. 15, 284-292 (1995).
114. Yung RL, Quddus J, Chrisp CE et al. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154, 3025-3035 (1995).
115. Badenhoop K, Walfish PG, Rau H et al. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune diseases. J. Clin. Endocrinol. MeTable 80, 2112-2117 (1995).
116. Tamura N, Iwase A, Suzuki K et al. Alveolar macrophages produce the Env protein of a human endogenous retrovirus, HERV-E 4-1, in a subgroup of interstitial lung diseases. Am. J. Respir. Cell Mol. Biol. 16, 429-437 (1997).
117. Dalen AB, Hellgren L, Iversen OJ, Vincent J. A virus-like particle associated with psoriasis. Acta Pathol. Microbiol. Immunol. Scand 9, 221-229 (1983).
118. Iversen OJ. Isolation of virus-like particles in urine from a psoriatic patient. Acta Pathol. Microbiol. Immunol. Scand 91, 407-412 (1983).
119. Guilhou JJ, Vannereau H, Theunynck D et al. Virological studies on psoriatic lymphocytes. In: Psoriasis. Farber EM, Cox AJ, Nall L, Jacobs PH (Eds). Grune and Stratton Inc, NY, USA, 251-252 (1982).
120. Bessis D, Moles JP, Basset-Seguin N et al. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin. Br. J. Dermatol. 151, 737-745 (2004).
121. Hohenadl C, Germaier H, Walchner M et al. Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J. Invest. Dermatol. 113, 587-594 (1999).
122. Moles JP, Tesniere A, Guilhou JJ. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. Br. J. Dermatol. 153, 83-89 (2005).
123. Andersson AC, Merza M, Venables P et al. Elevated levels of the endogenous retrovirus ERV3 in human sebaceous glands. J. Invest. Dermatol. 106, 125-128 (1996).
124. Kempf W, Kadin ME, Dvorak AM et al. Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis 24, 301-306 (2003).
125. Foerster J, Nolte I, Junge J et al. Haplotype sharing analysis identified a retroviral dUTPase as candidate susceptibility gene for psoriasis. J. Invest. Dermatol. 124, 99-102 (2005).
126. Bronson DL, Ritzi DM, Fraley EE et al. Morphologic evidence for retrovirus production by epithelial cells derived from a human testicular tumor metastasis. J. Natl Cancer Inst. 60, 1305-1308 (1978).
127. Bieda K, Hoffmann A, Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J. Gen. Virol. 82, 591-596 (2001).
128. Lower R, Boller K, Hasenmaier B et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc. Natl Acad. Sci. USA 90, 4480-4484 (1993).
129. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl Acad. Sci. USA 93, 5177-5184 (1996).
130. Sauter M, Schommer S, Kremmer E et al. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J. Virol. 60, 414-421 (1995).
131. Boller K, Janssen O, Schuldes H et al. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J. Virol. 71, 4581-4588 (1997).
132. Kleiman A, Senyuta N, Tryakin A et al. HERV-K(HML-2) gag/env antibodies as indicator for therapy effect in patients with germ line tumors. Int. J. Cancer 110, 459-461 (2004).
133. Galli UM, Sauter M, Lecher B et al. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 24, 3223-3228 (2005).
134. Menendez L, Benigno BB, McDonald JF. L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol. Cancer 3, 12 (2004).
135. Wang-Johanning F, Frost AR, Jian B et al. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma. Cancer 98, 187-197 (2003).
136. Schiavetti F, Thonnard J, Colau D et al. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res. 62, 5510-5516 (2002).
137. Muster T, Waltenberger A, Grassauer A et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res. 63, 8735-8741 (2003).
138. Buscher K, Trefzer U, Hofmann M et al. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res. 65, 4172-4180 (2005).
139. Misra A, Chosdol K, Sarkar C et al. Alteration of a sequence with homology to human endogenous retrovirus (HERV-K) in primary human glioma: implications for viral repeat mediated rearrangement. Mutat. Res. 484, 53-59 (2001).
140. Wang-Johanning F, Frost AR, Johanning GL et al. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clin. Cancer Res. 7, 1553-1560 (2001).
141. Wang-Johanning F, Frost AR, Jian B et al. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22, 1528-1535 (2003).
142. Ejthadi HD, Martin JH, Junying J et al. A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer. Arch. Virol. 150, 177-184 (2005).
143. Burmeister T, Ebert AD, Pritze W et al. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res. Hum. Retroviruses 20, 1223-1229 (2004).
144. Mant C, Gillett C, D'Arrigo C et al. Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies. Virology 318, 393-404 (2004).
145. Depil S, Roche C, Dussart P et al. Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia 16, 254-259 (2002).
146. Iwabuchi H, Kakihara T, Kobayashi T et al. A gene homologous to human endogenous retrovirus overexpressed in childhood acute lymphoblastic leukemia. Leuk. Lymphoma 45, 2303-2306 (2004).
147. Chaffanet M, Popovici C, Leroux D et al. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have dose or identical breakpoints in chromosome region 8p11-12. Oncogene 19, 945-949 (1998).
148. Guasch G, Popovici C, Mugneret F et al. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood 101, 286-288 (2003).
149. Brodsky I, Fuscaldo A, Erlick B et al. Analysis of platelets from patients with thrombocythemia for reverse transcriptase and virus-like particles. J. Natl Cancer Inst. 55, 1069-1074 (1975).
150. Boyd MT, Foley B, Brodsky I. Evidence for copurification of HERVK-related transcripts and a reverse transcriptase activity in human platelets from patients with essential thrombocythemia. Blood 90, 4022-4030 (1997).
151. Orenstein J. Human endogenous retroviral expression by leukocytes. Ultrastruct. Pathol. 24, 123-124 (2000).
152. Boyd MT, Maclean N, Oscier DG. Detection of retrovirus in patients with myeloproliferative disease. Lancet 1, 814-817 (1989).
153. Brodsky I, Foley B, Haines D et al. Expression of HERV-K proviruses in human leukocytes. Blood 81, 2369-2374 (1993).
154. Morgan D, Brodsky I. Human endogenous retrovirus (HERV-K) particles in megakaryocytes cultured from essential thrombocythemia peripheral blood stem cells. Exp. Hematology 32, 520-525 (2004).